Condition
Secondary Acute Myeloid Leukemia clinical trials and research
Research outlook What's coming for Acute myeloid leukemia: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 8 Secondary Acute Myeloid Leukemia clinical trials that are recruiting, at sites in 3 countries (most in United States (6), China (1), Germany (1)). By phase: Phase 1 (3), Phase 1/2 (3), Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 3Countries
Newest Secondary Acute Myeloid Leukemia clinical trials
All recruiting trials (8)
-
Decitabine plus FLAG‑Ida chemotherapy and total‑body irradiation before donor stem cell transplant for adults with high‑risk myeloid cancers
This test tries whether adding decitabine to FLAG‑Ida chemotherapy and total‑body irradiation before a donor stem cell transplant helps adults with high‑risk or relapsed myeloid blood cancers live longer and stay in remission.
-
Combining SNDX-5613 with standard chemotherapy for newly diagnosed acute myeloid leukemia
This study is testing a new drug called SNDX-5613 combined with standard chemotherapy to see if it can improve treatment for people with newly diagnosed acute myeloid leukemia that has certain genetic mutations.
-
Using Venetoclax with FLAMSA and Treosulfan for Blood Stem Cell Transplantation in Certain Blood Cancers
This study is testing if a new combination of medications can make blood stem cell transplants safer and more effective for people with certain serious blood cancers.
-
CAR T Cell Therapy for Recurrent or Refractory Acute Myeloid Leukemia
This study is testing a new CAR T-cell therapy to see if it can help people with recurring or hard-to-treat acute myeloid leukemia by using modified immune cells to attack cancer cells.
-
Using umbilical cord blood stem cells with azacitidine for advanced blood cancers
This study is testing whether using umbilical cord blood stem cells along with a medication called azacitidine can help people with advanced blood cancers who can't have traditional stem cell transplants.
-
Using edetate calcium disodium or succimer to treat acute myeloid leukemia or myelodysplastic syndrome during chemotherapy
This study is testing whether two drugs, edetate calcium disodium and succimer, can safely help people with acute myeloid leukemia or myelodysplastic syndrome feel better during chemotherapy.
-
Personalized NK cell therapy after umbilical cord blood transplant for leukemia
This study is testing if a special treatment using personalized immune cells from umbilical cord blood can help people with leukemia feel better after their transplant.
-
Combining cladribine, idarubicin, cytarabine, and venetoclax for treating certain blood cancers
This study is testing a new combination of four medications to see if it helps people with certain types of blood cancers feel better and live longer.
Related topics
Quick answers
How many Secondary Acute Myeloid Leukemia clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (6 trials), China (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 1/2: 3, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.